Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2185581rdf:typepubmed:Citationlld:pubmed
pubmed-article:2185581lifeskim:mentionsumls-concept:C1524059lld:lifeskim
pubmed-article:2185581lifeskim:mentionsumls-concept:C0012772lld:lifeskim
pubmed-article:2185581lifeskim:mentionsumls-concept:C0879626lld:lifeskim
pubmed-article:2185581lifeskim:mentionsumls-concept:C1611088lld:lifeskim
pubmed-article:2185581lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:2185581pubmed:issue10lld:pubmed
pubmed-article:2185581pubmed:dateCreated1990-6-1lld:pubmed
pubmed-article:2185581pubmed:abstractTextThe alcohol-sensitizing drugs disulfiram and calcium carbimide are often used in the treatment of alcohol problems with the hope of reducing alcohol consumption. These drugs inhibit the liver enzyme acetaldehyde dehydrogenase and, when taken prior to ethanol, produce an acetaldehyde-mediated aversive reaction. However, the drugs are unspecific, and several side effects may be related to their influence on other biochemical processes. These drugs are primarily pharmacological adjuncts and should be used in conjunction with behavioural and psychosocial therapies.lld:pubmed
pubmed-article:2185581pubmed:languagenorlld:pubmed
pubmed-article:2185581pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2185581pubmed:citationSubsetIMlld:pubmed
pubmed-article:2185581pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2185581pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2185581pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2185581pubmed:statusMEDLINElld:pubmed
pubmed-article:2185581pubmed:monthAprlld:pubmed
pubmed-article:2185581pubmed:issn0029-2001lld:pubmed
pubmed-article:2185581pubmed:authorpubmed-author:MørlandJJlld:pubmed
pubmed-article:2185581pubmed:authorpubmed-author:DuckertFFlld:pubmed
pubmed-article:2185581pubmed:authorpubmed-author:JohnsenJJlld:pubmed
pubmed-article:2185581pubmed:issnTypePrintlld:pubmed
pubmed-article:2185581pubmed:day10lld:pubmed
pubmed-article:2185581pubmed:volume110lld:pubmed
pubmed-article:2185581pubmed:ownerNLMlld:pubmed
pubmed-article:2185581pubmed:authorsCompleteYlld:pubmed
pubmed-article:2185581pubmed:pagination1224-8lld:pubmed
pubmed-article:2185581pubmed:dateRevised2008-7-16lld:pubmed
pubmed-article:2185581pubmed:meshHeadingpubmed-meshheading:2185581-...lld:pubmed
pubmed-article:2185581pubmed:meshHeadingpubmed-meshheading:2185581-...lld:pubmed
pubmed-article:2185581pubmed:meshHeadingpubmed-meshheading:2185581-...lld:pubmed
pubmed-article:2185581pubmed:meshHeadingpubmed-meshheading:2185581-...lld:pubmed
pubmed-article:2185581pubmed:meshHeadingpubmed-meshheading:2185581-...lld:pubmed
pubmed-article:2185581pubmed:year1990lld:pubmed
pubmed-article:2185581pubmed:articleTitle[Disulfiram and calcium carbimide. Mode of action, adverse effects and clinical use].lld:pubmed
pubmed-article:2185581pubmed:affiliationIncognito Klinikk, Statens rettstoksikologiske institutt, Oslo.lld:pubmed
pubmed-article:2185581pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2185581pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:2185581pubmed:publicationTypeReviewlld:pubmed